output
20092025
most citedWeakly Supervised Deep Nuclei Segmentation Using Partial Points Annotation in Histopathology Images

185 citations

12 papers

q-bio.QM2025

Normalization and selecting non-differentially expressed genes improve machine learning modelling of cross-platform transcriptomic data

Fei Deng, Catherine H Feng, Nan Gao +1

Normalization is a critical step in quantitative analyses of biological processes. Recent works show that cross-platform integration and normalization enable machine learning (ML)…

eess.IV2023★ 2 cited

Multi-Scale Feature Fusion using Parallel-Attention Block for COVID-19 Chest X-ray Diagnosis

Xiao Qi, David J. Foran, John L. Nosher +1

Under the global COVID-19 crisis, accurate diagnosis of COVID-19 from Chest X-ray (CXR) images is critical. To reduce intra- and inter-observer variability, during the radiological…

eess.IV2021★ 10 cited

Realistic Ultrasound Image Synthesis for Improved Classification of Liver Disease

Hui Che, Sumana Ramanathan, David Foran +3

With the success of deep learning-based methods applied in medical image analysis, convolutional neural networks (CNNs) have been investigated for classifying liver disease from ul…

eess.IV2021★ 2 cited

Multi-Feature Semi-Supervised Learning for COVID-19 Diagnosis from Chest X-ray Images

Xiao Qi, John L. Nosher, David J. Foran +1

Computed tomography (CT) and chest X-ray (CXR) have been the two dominant imaging modalities deployed for improved management of Coronavirus disease 2019 (COVID-19). Due to faster…

cs.CV2020★ 185 cited

Weakly Supervised Deep Nuclei Segmentation Using Partial Points Annotation in Histopathology Images

Hui Qu, Pengxiang Wu, Qiaoying Huang +7

Nuclei segmentation is a fundamental task in histopathology image analysis. Typically, such segmentation tasks require significant effort to manually generate accurate pixel-wise a…

q-bio.PE2020★ 79 cited

Understanding the role of phenotypic switching in cancer drug resistance

Einar Bjarki Gunnarsson, Subhajyoti De, Kevin Leder +1

The emergence of acquired drug resistance in cancer represents a major barrier to treatment success. While research has traditionally focused on genetic sources of resistance, rece…